SkyQuest Technology Group has recently published a comprehensive Cancer Diagnostics Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. The global cancer diagnostics market is undergoing significant transformation driven by advancements in technology, increasing cancer prevalence, and the growing demand for early detection tools. Healthcare systems worldwide are placing stronger emphasis on preventive care and timely diagnosis, which is fueling the adoption of innovative diagnostic methods.
Global Cancer Diagnostics Market size was valued at USD 21.6 billion in 2023 and is poised to grow from USD 23.63 billion in 2024 to USD 48.49 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).
Emerging economies are witnessing rising healthcare expenditure and infrastructure development, enabling broader access to cancer diagnostic services. Additionally, collaborations between research institutions, diagnostic companies, and healthcare providers are enhancing the speed and accuracy of cancer detection. The market is also benefiting from increased awareness campaigns and screening programs supported by governments and non-profit organizations. As a result, the cancer diagnostics landscape is becoming more accessible, efficient, and patient-centric, opening new opportunities for growth globally.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/cancer-diagnostics-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Cancer Diagnostics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
The Global Cancer Diagnostics Market is segmented by Product Type, Technology, Application, End-User Industry and region.
Based on Product Type, the market is segmented into Consumables and Instruments.
Based on Technology, the market is segmented into IVD Testing, Imaging and Biopsy Technique.
Based on Application, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma and Other Cancers.
Based on End-User Industry, the market is segmented into Hospitals, Diagnostic Laboratories and Others.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Cancer Diagnostics Market – Regional Analysis:
North America leads the global cancer diagnostics market, propelled by advanced healthcare infrastructure, significant R&D investments, and a high prevalence of cancer. The region’s dominance is further strengthened by the presence of major market players and supportive government initiatives.
Asia Pacific is experiencing rapid growth in the cancer diagnostics market due to rising healthcare expenditure, expanding patient populations, and technological advancements. Government initiatives and collaborations with international players are enhancing the availability of sophisticated diagnostic equipment.
South Korea’s cancer diagnostics market is bolstered by companies like Samsung Biologics, which partners with global pharmaceutical firms to develop and manufacture cancer therapies, enhancing the country’s diagnostic capabilities.
The UK’s cancer diagnostics market is evolving with the integration of AI in healthcare. The NHS is launching AI-enabled initiatives for breast screening to reduce waiting times, while private health scanning services are growing as more consumers seek quicker and more convenient services.
Top Market Players in Cancer Diagnostics Market are:
Abbott Laboratories (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Siemens Healthineers (Germany)
Thermo Fisher Scientific Inc. (USA)
GE Healthcare (USA)
Hologic Inc. (USA)
Illumina Inc. (USA)
Bio-Rad Laboratories Inc. (USA)
Agilent Technologies Inc. (USA)
bioMérieux SA (France)
Myriad Genetics Inc. (USA)
Qiagen N.V. (Netherlands)
PerkinElmer Inc. (USA)
Danaher Corporation (USA)
Recent Developments in Cancer Diagnostics Market:
In May 2025, Telangana has initiated a groundbreaking healthcare revamp by integrating artificial intelligence (AI) into cancer screening processes. The state will pilot AI-based screening in three districts, focusing on oral, breast, and cervical cancers. High-resolution imaging and AI algorithms will be used to detect abnormalities, which will then be referred for specialist evaluation. The MNJ Cancer Institute is leading the software development for this initiative.
In February 2025, Guardant Health experienced a significant stock surge after Medicare agreed to cover its colon cancer blood test, Guardant Reveal. This test detects recurrent cancer early by analyzing tumor DNA in a patient’s blood and was previously covered only for patients undergoing adjuvant therapy. The expanded reimbursement significantly broadens Guardant Health’s potential market reach.
In September 2024, Siemens Healthineers has secured a deal to purchase part of Novartis’s Advanced Accelerator Applications (AAA) business for over €200 million. This acquisition bolsters Siemens’ PET radiopharmaceutical business by supplying critical radioactive chemicals for cancer scans, enabling expansion in Europe.
You may Also Like
https://issuu.com/skyquest-technology/docs/carbon_credits_market_to_reach_usd_97.41_billion_b/s/87450246
https://issuu.com/guzusitechnext/docs/mining_chemicals_market.docx
Forward-Looking Insights
The Cancer Diagnostics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
